| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
| Quadri SK, Clark JL, Meit... |
Effects of LSD, Pargyline and Haloperidol on Mammary Tumor Growth in R... |
Proc.Soc.Exp.Biol.Me... |
1973 |
| Turek IS, Soskin RA, Kurl... |
Methylenedioxyamphetamine (MDA) Subjective Effects |
Journal of Psychedel... |
1974 |
| Goodrich CA, Hoff KM, Bak... |
The Maturational Effects of LSD upon Brain Weight and Behavior in the ... |
Comp Gen Pharmacol |
1974 |
| Quadri SK |
Effects Of Central Acting Drugs And Ergot Derivatives On Prolactin And... |
Assertation Abst. In... |
1974 |
| Quadri SK |
Effects of Central Acting Drugs and Ergot Derivatives on Prolactin and... |
Dissertation Abstr.I... |
1974 |
| Baker PC, Hoff KM |
The effects of LSD upon brain indoleamine maturation in the brain of t... |
Gen Pharmacol |
1975 |
| Pollock, S.H. |
Book Review: Growing Wild Mushrooms by B. Harris |
Journal of Psychoact... |
1976 |
| Poffenbarger M, Fuller GM |
Effects of Psychotropic Drugs on Neurotubule Assembly |
J.Neurochem. |
1977 |
| Demisch L, Neubauer M |
Stimulation of human prolactin secretion by mescaline |
Psychopharmacology (... |
1979 |
| Young RE, Milroy R, Hutch... |
The Rising Price Of Mushrooms |
The Lancet |
1982 |
| Montagne M |
Drug-taking paraphernalia |
J Psychoactive Drugs |
1983 |
| Wolfson PE |
Meetings at the edge with Adam: A man for all seasons? |
J Psychoactive Drugs |
1986 |
| Wilcox JA |
Psychoactive properties of methysergide |
J Psychoactive Drugs |
1987 |
| Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
| Gouzoulis E, von Bardeleb... |
Neuroendocrine and cardiovascular effects of MDE in healthy volunteers |
Neuropsychopharmacol... |
1993 |
| Newmeyer JA |
X at the crossroads |
J Psychoactive Drugs |
1993 |
| Strassman RJ, Qualls CR |
Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... |
Arch Gen Psychiatry |
1994 |
| Millman RB, Beeder AB |
The new psychedelic culture: LSD, ecstasy, 'rave' parties and the Grat... |
Psychiatric Annals |
1994 |
| Johnson EJ, Emche SD |
Variation of Alkaloid Content in Erythroxylum coca Leaves from Leaf Bu... |
Annals of Botany |
1994 |
| Aulakh CS, Mazzola-Pomiet... |
Role of various 5-HT receptor subtypes in mediating neuroendocrine eff... |
J Pharmacol Exp Ther |
1994 |
| Cornelius MD, Taylor PM, ... |
Prenatal tobacco and marijuana use among adolescents: effects on offsp... |
Pediatrics |
1995 |
| House RV, Thomas PT, Bhar... |
Selective modulation of immune function resulting from in vitro exposu... |
Toxicology |
1995 |
| Wright JD, Pearl L |
Knowledge and experience of young people regarding drug misuse, 1969-9... |
BMJ |
1995 |
| Seymour HR, Gilman D, Qui... |
Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged e... |
Diabet Med |
1996 |
| Buttar HS, Moffatt JH, Fo... |
Developmental toxicity of 4-substituted amphetamines in mice |
Reprod Toxicol |
1996 |
| Nakahara Y, Kikura R, Tak... |
Detection of LSD and metabolite in rat hair and human hair |
J Anal Toxicol |
1996 |
| Callaway JC, Raymon LP, H... |
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human ... |
J Anal Toxicol |
1996 |
| Nakahara Y, Kikura R |
Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethampheta... |
Biol Pharm Bull |
1997 |
| Kintz P, Cirimele V |
Interlaboratory comparison of quantitative determination of amphetamin... |
Forensic Sci Int |
1997 |
| Kikura R, Nakahara Y, Mie... |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxyme... |
Forensic Sci Int |
1997 |
| Grob CS, Poland RE. |
MDMA |
Substance Abuse: A C... |
1997 |
| Plessinger MA |
Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... |
Obstet Gynecol Clin ... |
1998 |
| Moeller MR, Steinmeyer S,... |
Determination of drugs of abuse in blood |
J Chromatogr B Biome... |
1998 |
| Clement BA, Goff CM, Forb... |
Toxic amines and alkaloids from Acacia rigidula |
Phytochemistry |
1998 |
| Abrahart D |
A Critical Review of Theories and Research Concerning Lysergic Acid Di... |
Masters Thesis |
1998 |
| Bertram M, Egelhoff T, Sc... |
Toxic leukencephalopathy following 'ecstasy' ingestion |
J Neurol |
1999 |
| McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
| Morgan MJ |
Ecstasy (MDMA): a review of its possible persistent psychological effe... |
Psychopharmacology (... |
2000 |
| Berman RM, Cappiello A, A... |
Antidepressant effects of ketamine in depressed patients |
Biol Psychiatry |
2000 |
| Nicotra AS, Parvez H |
Nitric Oxide and Neuronal and Pancreatic Beta Cell Death |
Toxicology |
2000 |
| Gorman EM, Carroll RT |
Substance abuse and HIV: considerations with regard to methamphetamine... |
J Assoc Nurses AIDS ... |
2000 |
| Rothman RB, Partilla JS, ... |
Neurochemical neutralization of methamphetamine with high-affinity non... |
Synapse |
2000 |
| Gross ST |
Detecting psychoactive drugs in the developmental stages of mushrooms |
J Forensic Sci |
2000 |
| Takayama H, Aimi N, Sakai... |
Chemical studies on the analgesic indole alkaloids from the traditiona... |
Yakugaku Zasshi |
2000 |
| Pacifici R, Zuccaro P, Lo... |
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combin... |
J Pharmacol Exp Ther |
2001 |
| Zakzanis K, Young DA |
Executive function in abstinent MDMA ('ecstasy') users |
Medical Science Moni... |
2001 |
| Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
| Moeller MR, Kraemer T |
Drugs of abuse monitoring in blood for control of driving under the in... |
Ther Drug Monit |
2002 |
| Gerra G, Zaimovic A, Moi ... |
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopam... |
Behav Brain Res |
2002 |
| Brecht ML, von Mayrhauser... |
Differences between ecstasy-using and non-using methamphetamine users |
J Psychoactive Drugs |
2002 |
| Passie T, Seifert J, Schn... |
The pharmacology of psilocybin |
Addict Biol |
2002 |
| Williams MT, Morford LL, ... |
Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequent... |
Brain Res |
2003 |
| Romanelli F, Smith KM, Po... |
Use of club drugs by HIV-seropositive and HIV-seronegative gay and bis... |
Top HIV Med |
2003 |
| Yacoubian GS |
Correlates of ecstasy use among students surveyed through the 1997 Col... |
J Drug Educ |
2003 |
| Schenk S, Gittings D, Joh... |
Development, maintenance and temporal pattern of self-administration m... |
Psychopharmacology (... |
2003 |
| Engelsman EL |
Cannabis Control: the model of the WHO tobacco control treaty |
International Journa... |
2003 |
| Gerra G, Bassignana S, Za... |
Hypothalamic-pituitary-adrenal axis responses to stress in subjects wi... |
Psychiatry Res |
2003 |
| Jacobsen LK, Mencl WE, Pu... |
Preliminary evidence of hippocampal dysfunction in adolescent MDMA ('e... |
Psychopharmacology (... |
2003 |
| Pacifici R, Pichini S, Zu... |
Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Huma... |
J Pharmacol Exp Ther |
2004 |
| Halpern JH |
Hallucinogens and dissociative agents naturally growing in the United ... |
Pharmacol Ther |
2004 |
| Parks KA, Kennedy CL |
Club Drugs: Reasons for and Consequences of Use |
J Psychoactive Drugs |
2004 |
| Narendran R, Frankle WG, ... |
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... |
Am J Psychiatry |
2005 |
| Budayova-Spano M, Dauverg... |
A methodology and an instrument for the temperature-controlled optimiz... |
Acta Crystallogr D B... |
2007 |
| Silins E, Copeland J, Dil... |
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use o... |
Aust N Z J Psychiatr... |
2007 |
| Sessa B, Nutt DJ |
MDMA, politics and medical research: have we thrown the baby out with ... |
J Psychopharmacol |
2007 |
| Tekbas OF, Ogur R, Korkma... |
Melatonin as an antibiotic: new insights into the actions of this ubiq... |
J Pineal Res |
2008 |
| Students T |
Validation of a Gas Chromatography Method for Analysis of Medicinal-Qu... |
erowid |
2008 |
| Lucas PG |
Regulating compassion: an overview of Canada's federal medical cannabi... |
Harm Reduct J |
2008 |
| Neukamm MA, Mürdter TE, W... |
Quantitative determination of the active ’Spice’ ingredient JWH-018 in... |
|
2008 |
| Lipton JW, Tolod EG, Thom... |
3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival o... |
Neuropharmacology |
2008 |
| Lidder S, Dargan P, Sexto... |
Cardiovascular toxicity associated with recreational use of diphenylpr... |
J Med Toxicol |
2008 |
| Sessa B |
Is it time to revisit the role of psychedelic drugs in enhancing human... |
J Psychopharmacol |
2008 |
| Carter C |
Making residential cannabis growing operations actionable: a critical ... |
Int J Drug Policy |
2009 |
| Vogels N, Brunt TM, Rigte... |
Content of ecstasy in the Netherlands: 1993-2008 |
Addiction |
2009 |
| Baggott MJ, Erowid E, Ero... |
Use patterns and self-reported effects of Salvia divinorum: An interne... |
Drug Alcohol Depend |
2010 |
| Wohlfarth A, Weinmann W |
Bioanalysis of new designer drugs |
|
2010 |
| McElrath K, O'Neill C |
Experiences with mephedrone pre- and post-legislative controls: Percep... |
Int J Drug Policy |
2011 |
| Durham M |
Ivory wave: the next mephedrone? |
Emerg Med J |
2011 |
| Corazza O, Schifano F, Fa... |
Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emerg... |
Curr Clin Pharmacol |
2011 |
| Antonowicz JL, Metzger AK... |
Paranoid psychosis induced by consumption of methylenedioxypyrovaleron... |
Gen Hosp Psychiatry |
2011 |
| Rodgers J, Buchanan T, He... |
'Ecstasy use, by itself, does not result in residual neurotoxicity'- a... |
Addiction |
2011 |
| Spiller HA, Ryan ML, West... |
Clinical experience with and analytical confirmation of 'bath salts' a... |
Clin Toxicol (Phila) |
2011 |
| Casselman I, Heinrich M |
Novel Use Patterns of Salvia divinorum: Unobtrusive Observation using ... |
Journal of Ethnophar... |
2011 |
| Ward J, Rhyee S, Plansky ... |
Methoxetamine: a novel ketamine analog and growing health-care concern |
Clin Toxicol (Phila) |
2011 |
| Olives TD, Orozco BS, Ste... |
Bath salts: the ivory wave of trouble |
West J Emerg Med |
2012 |
| Caldeira KM, O'Grady KE, ... |
Marijuana use trajectories during the post-college transition: Health ... |
Drug Alcohol Depend |
2012 |
| Corazza O, Schifano F, Si... |
Phenomenon of new drugs on the Internet: the case of ketamine derivati... |
Hum Psychopharmacol |
2012 |
| Gallagher CT, Assi S, Sta... |
5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal ... |
Hum Psychopharmacol |
2012 |
| Prosser JM, Nelson LS |
The Toxicology of Bath Salts: A Review of Synthetic Cathinones |
J Med Toxicol |
2012 |
| Toole KE, Fu S, Shimmon R... |
Color Tests for the Preliminary Identification of Methcathinone and An... |
Microgram |
2012 |
| Baumann MH, Partilla JS, ... |
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... |
Neuropsychopharmacol... |
2013 |
| Johnson LA, Johnson RL, P... |
Current 'Legal Highs' |
J Emerg Med |
2013 |
| Daniulaityte R, Carlson R... |
I just wanted to tell you that loperamide WILL WORK: a web-based study... |
Drug Alcohol Depend |
2013 |
| Chary M, Genes N, McKenzi... |
Leveraging social networks for toxicovigilance |
J Med Toxicol |
2013 |
| Patton AL, Seely KA, Pull... |
Quantitative Measurement of Acetyl Fentanyl and Acetyl Norfentanyl in ... |
Anal Chem |
2014 |
| Oram M |
Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments ... |
J Hist Med Allied Sc... |
2014 |
| Appendino G, Minassi A, T... |
Recreational drug discovery: natural products as lead structures for t... |
Natural Products Rep... |
2014 |
| Helander A, Bäckberg M, B... |
MT-45, a new psychoactive substance associated with hearing loss and u... |
Clin Toxicol (Phila) |
2014 |
| Katselou M, Papoutsis I, ... |
AH-7921: the list of new psychoactive opioids is expanded |
Forensic Toxicol |
2015 |
